NCT06532318

Comparative Study Between Platelet Rich Plasma and Steroid Injection in Trigger Finger Treatment

Comparative Study Between Intralesional Injection of Platelet Rich Plasma and Intralesional Steroid for the Treatment of Trigger Finger in Black Patients

• Status: Not Yet Recruiting
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Obafemi Awolowo University Teaching Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The goal of this clinical trial is to learn if platelet rich plasma works to treat early stage trigger finger in adults. It will also learn about the safety platelet rich plasma. The main questions it aims to answer are: Does platelet rich plasma lower the pain associated with trigger finger of participants? Does it improve the hand grip strength and Q DASH score of participants? Researchers will compare platelet rich plasma to Depo-Medrol steroid (a known standard of care for early stage trigger finger) to see if platelet rich plasma works to treat early trigger finger. Participants will: Take platelet rich plasma or a depo-medrol steroid intralesional injection at recruitment into the intervention Visit the clinic once every 4 weeks for checkups and parameter measurements. Investigator will will keep a record of participants progress in symptom remission

Conditions

• Trigger Finger Disorder

Interventions

Type	Name	Description
BIOLOGICAL	Platelet rich plasma	Freshly prepared autologus platelet rich plasma
DRUG	Pfizer Depo-medrol	Methylprednisolone acetate 20mg/ml injection

Timeline

• Start date: 2024-07-24
• Primary completion: 2024-12-23
• Completion: 2025-06-23
• First posted: 2024-08-01
• Last updated: 2024-08-01